What’s Trending in IVD – April 2017

    Published: April 24, 2017 | Price: $200.00 – $400.00

    A look at key trends in in vitro diagnostics in the month of April 2017.
    What’s Trending in IVD – May 2017

    Published: May 26, 2017 | Price: $200.00 – $400.00

    This report describes major trends in the in vitro diagnostic industry
    IVD Trends July 2017

    Published: August 15, 2017 | Price: $200.00 – $400.00

    Coverage of major IVD industry events and trends July 2017.
    Selected New Products in IVD

    Published: October 19, 2017 | Price: $200.00 – $400.00

    New products in IVD, as launched at major diagnostic conventions.
    U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays

    Published: March 1, 2003 | Price: $250.00 – $5,250.00

    The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. Where chips were initially envisioned as carriers of microscopic binding sites...
    In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies

    Published: May 1, 2009 | Price: $250.00 – $3,395.00

    It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...
    H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

    Published: May 1, 2009 | Price: $250.00 – $1,600.00

    The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...
    Roche Diagnostics: Company Profile

    Published: November 2, 2015 | Price: $250.00 – $500.00

    Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world's largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world's largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche's personalized healthcare strategy aims at providing medicines...
    QIAGEN: Company Profile

    Published: November 9, 2015 | Price: $250.00 – $500.00

    QIAGEN: Company Profile QIAGEN, a leading global provider of sample and assay technologies, markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). QIAGEN: Company Profile examines the global healthcare company whose sample technologies isolate and process DNA, RNA and proteins from biological samples such as blood...
    IVD Trends Fall 2017

    Published: October 2, 2018 | Price: $250.00 – $500.00

    Trends in IVD Fall of 2017
    POC Urinalysis Testing Market: Forecasts to 2019

    Published: December 17, 2015 | Price: $349.30 – $700.00

    Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...
    Diabetes in France: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

    Published: March 1, 2003 | Price: $371.00 – $742.00

    Diabetes monitoring and therapeutics to manage the disease and its complications continues to be an attractive market for many manufacturers. However, the factors that affect the potential of diabetes markets—including population demographics and the attitude of healthcare policy makers and clinicians—can seem like shifting sands from one country to the next. That’s why Kalorama is now offering affordable country-specific profiles on the diabetes markets that provide you with the facts you need to implement your strategy in each of the...
    Diabetes in Germany: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

    Published: April 1, 2003 | Price: $371.00 – $742.00

    The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics, biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. Scope and Methodology In addition to epidemiology of diabetes Type...
    Diabetes in Japan: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

    Published: April 1, 2003 | Price: $371.00 – $742.00

    The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics, biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. Scope and Methodology In addition to epidemiology of diabetes Type...
    Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures, 2002-2006

    Published: October 1, 2004 | Price: $395.00 – $790.00

    Based on findings from Kalorama Information’s research study Facial Cosmetic Surgery and Rejuvenation Markets: Business, Technologies, and Competitive Intelligence (July 2004), this summary covers the top five surgeries and an “other” category. The top five procedures are: Breast augmentation/reduction Liposuction Rytidectomy (face lifts) Blepharoplasty (eyelid lift) Rhinoplasty (nose job) The analysis includes data on procedures and revenues for surgery but not market data for conventional surgical instruments and equipment. The “other” category includes such procedures as tummy tucks , buttocks...